JAMP TRETINOIN
Identification of Jamp Tretinoin
| No description |
Google image searchProduct monograph
Active ingredient
tretinoin, 10 MG
DIN: 02520036
Dosage form(s): CAPSULE
Route(s) of administration: ORAL
Schedule: Prescription
Company: JAMP PHARMA CORPORATION
Date: 29-AUG-2022
ATC:
- L01 — ANTINEOPLASTIC AGENTS (ATC, ATC/DDD, )
- L01X — OTHER ANTINEOPLASTIC AGENTS (ATC, ATC/DDD)
- L01XF — Retinoids for cancer treatment (ATC, ATC/DDD)
- L01XF01 — TRETINOIN (ATC/DDD)
Reference brand drug: Retin-a, Stieva-a
Pharmaceutical standard: MFR
